Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention: 19 September 1990, Stockholm, Sweden
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
London u.a.
Acad. Press
1992
|
Schriftenreihe: | [European heart journal / Supplement]
13B |
Schlagworte: | |
Beschreibung: | Literaturangaben |
Beschreibung: | III, 36 S. Ill., graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV005456181 | ||
003 | DE-604 | ||
005 | 19990316 | ||
007 | t | ||
008 | 920731s1992 ad|| |||| 10||| eng d | ||
035 | |a (OCoLC)26365421 | ||
035 | |a (DE-599)BVBBV005456181 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-12 |a DE-355 |a DE-29 | ||
245 | 1 | 0 | |a Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention |b 19 September 1990, Stockholm, Sweden |c ed. by J. L. Goldstein ... |
264 | 1 | |a London u.a. |b Acad. Press |c 1992 | |
300 | |a III, 36 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a [European heart journal / Supplement] |v 13B | |
500 | |a Literaturangaben | ||
650 | 4 | |a Coronary Disease |x prevention & control |v Congresses | |
650 | 4 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors |v Congresses | |
650 | 4 | |a Hypercholesterolemia |x drug therapy |v Congresses | |
650 | 0 | 7 | |a Simvastatin |0 (DE-588)4277211-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hypercholesterinämie |0 (DE-588)4161049-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Prävention |0 (DE-588)4076308-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hydroxymethylglutaryl-CoA-Reductase |0 (DE-588)4161000-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Lovastatin |0 (DE-588)4279866-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Koronare Herzkrankheit |0 (DE-588)4073731-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Inhibitor |0 (DE-588)4027007-5 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1990 |z Stockholm |2 gnd-content | |
689 | 0 | 0 | |a Koronare Herzkrankheit |0 (DE-588)4073731-7 |D s |
689 | 0 | 1 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Koronare Herzkrankheit |0 (DE-588)4073731-7 |D s |
689 | 1 | 1 | |a Prävention |0 (DE-588)4076308-0 |D s |
689 | 1 | 2 | |a Hypercholesterinämie |0 (DE-588)4161049-0 |D s |
689 | 1 | 3 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Hypercholesterinämie |0 (DE-588)4161049-0 |D s |
689 | 2 | 1 | |a Simvastatin |0 (DE-588)4277211-4 |D s |
689 | 2 | |5 DE-604 | |
689 | 3 | 0 | |a Hypercholesterinämie |0 (DE-588)4161049-0 |D s |
689 | 3 | 1 | |a Lovastatin |0 (DE-588)4279866-8 |D s |
689 | 3 | |5 DE-604 | |
689 | 4 | 0 | |a Hydroxymethylglutaryl-CoA-Reductase |0 (DE-588)4161000-3 |D s |
689 | 4 | 1 | |a Inhibitor |0 (DE-588)4027007-5 |D s |
689 | 4 | 2 | |a Koronare Herzkrankheit |0 (DE-588)4073731-7 |D s |
689 | 4 | |5 DE-604 | |
700 | 1 | |a Goldstein, Joseph L. |e Sonstige |4 oth | |
810 | 2 | |a Supplement] |t [European heart journal |v 13B |w (DE-604)BV000900709 |9 13B | |
999 | |a oai:aleph.bib-bvb.de:BVB01-003413930 |
Datensatz im Suchindex
_version_ | 1804119667476791296 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV005456181 |
ctrlnum | (OCoLC)26365421 (DE-599)BVBBV005456181 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02728nam a2200649 cb4500</leader><controlfield tag="001">BV005456181</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990316 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">920731s1992 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)26365421</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005456181</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention</subfield><subfield code="b">19 September 1990, Stockholm, Sweden</subfield><subfield code="c">ed. by J. L. Goldstein ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London u.a.</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">III, 36 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">[European heart journal / Supplement]</subfield><subfield code="v">13B</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Coronary Disease</subfield><subfield code="x">prevention & control</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hydroxymethylglutaryl-CoA Reductase Inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypercholesterolemia</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Simvastatin</subfield><subfield code="0">(DE-588)4277211-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypercholesterinämie</subfield><subfield code="0">(DE-588)4161049-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hydroxymethylglutaryl-CoA-Reductase</subfield><subfield code="0">(DE-588)4161000-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lovastatin</subfield><subfield code="0">(DE-588)4279866-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Koronare Herzkrankheit</subfield><subfield code="0">(DE-588)4073731-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1990</subfield><subfield code="z">Stockholm</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Koronare Herzkrankheit</subfield><subfield code="0">(DE-588)4073731-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Koronare Herzkrankheit</subfield><subfield code="0">(DE-588)4073731-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Hypercholesterinämie</subfield><subfield code="0">(DE-588)4161049-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Hypercholesterinämie</subfield><subfield code="0">(DE-588)4161049-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Simvastatin</subfield><subfield code="0">(DE-588)4277211-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Hypercholesterinämie</subfield><subfield code="0">(DE-588)4161049-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Lovastatin</subfield><subfield code="0">(DE-588)4279866-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Hydroxymethylglutaryl-CoA-Reductase</subfield><subfield code="0">(DE-588)4161000-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="2"><subfield code="a">Koronare Herzkrankheit</subfield><subfield code="0">(DE-588)4073731-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldstein, Joseph L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement]</subfield><subfield code="t">[European heart journal</subfield><subfield code="v">13B</subfield><subfield code="w">(DE-604)BV000900709</subfield><subfield code="9">13B</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003413930</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1990 Stockholm gnd-content |
genre_facet | Konferenzschrift 1990 Stockholm |
id | DE-604.BV005456181 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:29:50Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003413930 |
oclc_num | 26365421 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-29 |
owner_facet | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-29 |
physical | III, 36 S. Ill., graph. Darst. |
publishDate | 1992 |
publishDateSearch | 1992 |
publishDateSort | 1992 |
publisher | Acad. Press |
record_format | marc |
series2 | [European heart journal / Supplement] |
spelling | Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention 19 September 1990, Stockholm, Sweden ed. by J. L. Goldstein ... London u.a. Acad. Press 1992 III, 36 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier [European heart journal / Supplement] 13B Literaturangaben Coronary Disease prevention & control Congresses Hydroxymethylglutaryl-CoA Reductase Inhibitors Congresses Hypercholesterolemia drug therapy Congresses Simvastatin (DE-588)4277211-4 gnd rswk-swf Hypercholesterinämie (DE-588)4161049-0 gnd rswk-swf Prävention (DE-588)4076308-0 gnd rswk-swf Lipidstoffwechsel (DE-588)4035875-6 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 gnd rswk-swf Lovastatin (DE-588)4279866-8 gnd rswk-swf Koronare Herzkrankheit (DE-588)4073731-7 gnd rswk-swf Inhibitor (DE-588)4027007-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1990 Stockholm gnd-content Koronare Herzkrankheit (DE-588)4073731-7 s Lipidstoffwechsel (DE-588)4035875-6 s DE-604 Prävention (DE-588)4076308-0 s Hypercholesterinämie (DE-588)4161049-0 s Pharmakotherapie (DE-588)4076066-2 s Simvastatin (DE-588)4277211-4 s Lovastatin (DE-588)4279866-8 s Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 s Inhibitor (DE-588)4027007-5 s Goldstein, Joseph L. Sonstige oth Supplement] [European heart journal 13B (DE-604)BV000900709 13B |
spellingShingle | Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention 19 September 1990, Stockholm, Sweden Coronary Disease prevention & control Congresses Hydroxymethylglutaryl-CoA Reductase Inhibitors Congresses Hypercholesterolemia drug therapy Congresses Simvastatin (DE-588)4277211-4 gnd Hypercholesterinämie (DE-588)4161049-0 gnd Prävention (DE-588)4076308-0 gnd Lipidstoffwechsel (DE-588)4035875-6 gnd Pharmakotherapie (DE-588)4076066-2 gnd Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 gnd Lovastatin (DE-588)4279866-8 gnd Koronare Herzkrankheit (DE-588)4073731-7 gnd Inhibitor (DE-588)4027007-5 gnd |
subject_GND | (DE-588)4277211-4 (DE-588)4161049-0 (DE-588)4076308-0 (DE-588)4035875-6 (DE-588)4076066-2 (DE-588)4161000-3 (DE-588)4279866-8 (DE-588)4073731-7 (DE-588)4027007-5 (DE-588)1071861417 |
title | Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention 19 September 1990, Stockholm, Sweden |
title_auth | Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention 19 September 1990, Stockholm, Sweden |
title_exact_search | Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention 19 September 1990, Stockholm, Sweden |
title_full | Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention 19 September 1990, Stockholm, Sweden ed. by J. L. Goldstein ... |
title_fullStr | Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention 19 September 1990, Stockholm, Sweden ed. by J. L. Goldstein ... |
title_full_unstemmed | Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention 19 September 1990, Stockholm, Sweden ed. by J. L. Goldstein ... |
title_short | Lipid regulation with HMG CoA reductase inhibitors and the future of CHD prevention |
title_sort | lipid regulation with hmg coa reductase inhibitors and the future of chd prevention 19 september 1990 stockholm sweden |
title_sub | 19 September 1990, Stockholm, Sweden |
topic | Coronary Disease prevention & control Congresses Hydroxymethylglutaryl-CoA Reductase Inhibitors Congresses Hypercholesterolemia drug therapy Congresses Simvastatin (DE-588)4277211-4 gnd Hypercholesterinämie (DE-588)4161049-0 gnd Prävention (DE-588)4076308-0 gnd Lipidstoffwechsel (DE-588)4035875-6 gnd Pharmakotherapie (DE-588)4076066-2 gnd Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 gnd Lovastatin (DE-588)4279866-8 gnd Koronare Herzkrankheit (DE-588)4073731-7 gnd Inhibitor (DE-588)4027007-5 gnd |
topic_facet | Coronary Disease prevention & control Congresses Hydroxymethylglutaryl-CoA Reductase Inhibitors Congresses Hypercholesterolemia drug therapy Congresses Simvastatin Hypercholesterinämie Prävention Lipidstoffwechsel Pharmakotherapie Hydroxymethylglutaryl-CoA-Reductase Lovastatin Koronare Herzkrankheit Inhibitor Konferenzschrift 1990 Stockholm |
volume_link | (DE-604)BV000900709 |
work_keys_str_mv | AT goldsteinjosephl lipidregulationwithhmgcoareductaseinhibitorsandthefutureofchdprevention19september1990stockholmsweden |